» Articles » PMID: 14984178

The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: Design, Development and Data Assessed

Overview
Date 2004 Feb 27
PMID 14984178
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Many issues plague the pediatric ARF outcome literature, which include data only from single center sources, a relative lack of prospective study, mixture within studies of renal replacement therapy modality without stratification and inconsistent use of methods to control for patient illness severity in outcome analysis. Since January 2001, the Prospective Pediatric CRRT (ppCRRT) Registry Group has been collecting data from multiple United States pediatric centers to obtain demographic data regarding pediatric patients who receive CRRT, assess the effect of different CRRT prescriptions on circuit function and evaluate the impact of clinical variables on patient outcome. The aim of the current paper is to describe the ppCRRT Registry design, review the decision process and rationale for the options chosen for the ppCRRT format and discuss the analysis plan and future projects envisioned for the ppCRRT Registry.

Citing Articles

Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy.

Hambrick H, Cervantes F, Dong M, Tang P, Arbough T, Vinks A J Pediatr Pharmacol Ther. 2024; 29(2):180-187.

PMID: 38596427 PMC: 11001209. DOI: 10.5863/1551-6776-29.2.180.


Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.

Starr M, Gist K, Zang H, Ollberding N, Balani S, Cappoli A Am J Kidney Dis. 2024; 84(4):406-415.e1.

PMID: 38364956 PMC: 11324858. DOI: 10.1053/j.ajkd.2023.12.017.


The twenty-sixth Acute Disease Quality Initiative: the Pediatric ADQI (pADQI)-a dream realized.

Goldstein S Pediatr Nephrol. 2023; 39(3):917-918.

PMID: 38114771 DOI: 10.1007/s00467-023-06253-w.


Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.

Pavia K, Hambrick H, Paice K, Tang P, Punt N, Kaplan J J Antimicrob Chemother. 2023; 78(9):2140-2147.

PMID: 37466170 PMC: 10477133. DOI: 10.1093/jac/dkad192.


Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children.

Sun Y, Li D, Bai K, Xu F, Liu C, Dang H Front Pediatr. 2023; 11:1086420.

PMID: 37397150 PMC: 10310529. DOI: 10.3389/fped.2023.1086420.